PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI)

14 filings reported holding PALI - PALISADE BIO, INC. - Common Stock, par value $0.01 per share as of Q2 2025.
PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 84.6K shares of 100M outstanding shares and own 0.08% of the company stock.
Largest 10 shareholders include XTX Topco Ltd (27.3K shares), GEODE CAPITAL MANAGEMENT, LLC (24.7K shares), TWO SIGMA SECURITIES, LLC (16K shares), Newbridge Financial Services Group, Inc. (10.5K shares), Tower Research Capital LLC (TRC) (4.57K shares), Transce3nd, LLC (1K shares), UBS Group AG (332 shares), Federation des caisses Desjardins du Quebec (100 shares), BANK OF AMERICA CORP /DE/ (45 shares), and WELLS FARGO & COMPANY/MN (21 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.